Advertisement

Topics

TA Associates Announces Investment in Ideal Cures

00:00 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
TA Associates, a leading global growth private equity firm, today announced it has completed an investment in Ideal Cures Private Limited, a supplier of ready-to-use coating products and excipients for tablets and capsules to th...

Other Sources for this Article

For Ideal Cures:
Ideal Cures
Suresh Pareek, +91 22 42688 711
pareeksuresh@idealcures.com
or
For TA Associates:
TA Associates
Marcia O’Carroll, 617-574-6796
mocarroll@ta.com
or
BackBay Communications
Stephen Fishleigh, +44 203-475-7552
stephen.fishleigh@backbaycommunications.com
or
Zachary Tramonti, 617-391-0797
zachary.tramonti@backbaycommunications.com

NEXT ARTICLE

More From BioPortfolio on "TA Associates Announces Investment in Ideal Cures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...